1. Home
  2. EGY vs TECX Comparison

EGY vs TECX Comparison

Compare EGY & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VAALCO Energy Inc.

EGY

VAALCO Energy Inc.

HOLD

Current Price

$3.54

Market Cap

412.9M

Sector

Energy

ML Signal

HOLD

Logo Tectonic Therapeutic Inc. Common Stock

TECX

Tectonic Therapeutic Inc. Common Stock

HOLD

Current Price

$19.70

Market Cap

359.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
EGY
TECX
Founded
1985
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
412.9M
359.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
EGY
TECX
Price
$3.54
$19.70
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$81.20
AVG Volume (30 Days)
822.3K
328.2K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
7.06%
N/A
EPS Growth
N/A
N/A
EPS
0.27
N/A
Revenue
$389,951,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$21.53
N/A
P/E Ratio
$13.11
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.00
$13.70
52 Week High
$5.08
$61.07

Technical Indicators

Market Signals
Indicator
EGY
TECX
Relative Strength Index (RSI) 44.05 52.30
Support Level $3.44 $18.60
Resistance Level $3.66 $21.50
Average True Range (ATR) 0.11 1.65
MACD 0.00 -0.07
Stochastic Oscillator 44.20 47.69

Price Performance

Historical Comparison
EGY
TECX

About EGY VAALCO Energy Inc.

VAALCO Energy Inc is an independent energy company operating in the United States. It is principally engaged in the acquisition, exploration, development, and production of crude oil and natural gas. The company operates through geographical segments namely Gabon, Egypt, Canada, Equatorial Guinea, and Cote d'Ivoire. The company generates maximum revenue from the Gabon segment.

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: